Contact us   |  

Advances in Prenatal Diagnosis of monogenic diseases : “Coelocentesis”

Advances in Prenatal Diagnosis of monogenic diseases : “Coelocentesis”

2021-02-26
Advances in Prenatal Diagnosis of monogenic diseases :  “Coelocentesis”

"Embryo-fetal erythroid cell selection from celomic fluid allows earlier prenatal diagnosis of hemoglobinopathies" the study coordinated by  the ERN-Eurobloodnet member Prof. Aurelio Maggio, in collaboration with the "Franco e Piera Cutino" Foundation

We share with you an important work published in the scientific journal "Prenatal Diagnosis" entitled: "Embryo-fetal erythroid cell selection from celomic fluid allows earlier prenatal diagnosis of hemoglobinopathies".

"Coelocentesis" is a recent prenatal diagnosis procedure, potentially performable on all monogenic genetic diseases, allowing, compared to classic procedures (eg: CVS and amniocentesis) to know the health status of the fetus much earlier, around 7-9 weeks of gestation.

The study group that developed the procedure was coordinated by the ERN-Eurobloodnet member Prof. Aurelio Maggio (Riuniti hospitals Villa Sofia-Cervello - Palermo), in collaboration with the "Franco e Piera Cutino" Foundation